临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2014年
14期
6-7
,共2页
急性左心衰竭%硝普钠%西地兰
急性左心衰竭%硝普鈉%西地蘭
급성좌심쇠갈%초보납%서지란
Acute left heart failure%Sodium nitroprusside%Cedilanid
目的:研究硝普钠与西地兰治疗急性左心衰竭患者中的有效性和安全性。方法选取医院心内科住院急性左心衰竭病患者56例,随机分为硝普钠组与西地兰组各28例。2组在常规治疗基础上分别予硝普钠及西地兰治疗,比较2组患者血压、心率、症状缓解时间、不良反应等。结果2组患者血压和心率情况均得到良好控制,硝普钠组控制情况优于西地兰组,差异有统计学意义(P ﹤0.05)。2种药物对急性左心衰竭治疗均具良好效果(有效率﹥90%);硝普钠组心力衰竭症状缓解所需时间更短,起效更快,差异有统计学意义(P ﹤0.05)。2组治疗后均未出现心律失常、血压下降过快、休克等不良反应。结论硝普钠与西地兰治疗急性左心衰竭均有明显效果,安全性较高;硝普钠对比西地兰在治疗效果、起效时间上具有优势。
目的:研究硝普鈉與西地蘭治療急性左心衰竭患者中的有效性和安全性。方法選取醫院心內科住院急性左心衰竭病患者56例,隨機分為硝普鈉組與西地蘭組各28例。2組在常規治療基礎上分彆予硝普鈉及西地蘭治療,比較2組患者血壓、心率、癥狀緩解時間、不良反應等。結果2組患者血壓和心率情況均得到良好控製,硝普鈉組控製情況優于西地蘭組,差異有統計學意義(P ﹤0.05)。2種藥物對急性左心衰竭治療均具良好效果(有效率﹥90%);硝普鈉組心力衰竭癥狀緩解所需時間更短,起效更快,差異有統計學意義(P ﹤0.05)。2組治療後均未齣現心律失常、血壓下降過快、休剋等不良反應。結論硝普鈉與西地蘭治療急性左心衰竭均有明顯效果,安全性較高;硝普鈉對比西地蘭在治療效果、起效時間上具有優勢。
목적:연구초보납여서지란치료급성좌심쇠갈환자중적유효성화안전성。방법선취의원심내과주원급성좌심쇠갈병환자56례,수궤분위초보납조여서지란조각28례。2조재상규치료기출상분별여초보납급서지란치료,비교2조환자혈압、심솔、증상완해시간、불량반응등。결과2조환자혈압화심솔정황균득도량호공제,초보납조공제정황우우서지란조,차이유통계학의의(P ﹤0.05)。2충약물대급성좌심쇠갈치료균구량호효과(유효솔﹥90%);초보납조심력쇠갈증상완해소수시간경단,기효경쾌,차이유통계학의의(P ﹤0.05)。2조치료후균미출현심률실상、혈압하강과쾌、휴극등불량반응。결론초보납여서지란치료급성좌심쇠갈균유명현효과,안전성교고;초보납대비서지란재치료효과、기효시간상구유우세。
Objective To study the efficacy and safety of sodium nitroprusside and cedilanid in the treatment of pa-tients with acute left heart failure. Methods 56 cases of patients diagnosed acute left heart failure in the Department of Cardi-ology in our hospital were selected and randomly divided into sodium nitroprusside group and cedilanid group,each of 28 ca-ses. Bases on the routine treatment,the 2 groups were treated with sodium nitroprusside and cedilanid respectively. The blood pressure,heart rate,time of symptom relief,adverse reaction and etc were compared. Results Blood pressure and heart rate of 2 groups were well controlled,but the sodium nitroprusside group was better than that of cedilanid group,the difference was sta-tistically significant(P ﹤ 0. 05). Both drugs were effective in the patients with acute left heart failure(effective rate ﹥ 90% ). The heart failure symptoms time was shorter in sodium nitroprusside group compared with cedilanid group,the difference was statistically significant(P ﹤ 0. 05). Both groups had no adverse reaction such as arrhythmia,Blood pressure drop too fast, shock,etc. Conclusion Sodium nitroprusside and cedilanid were in effect in the treatment of acute left heart failure,with high security,but the sodium nitroprusside has advantages in treatment effect and onset time.